VG Life Sciences Inc.
VGLS
$0.00
$0.000.00%
| 09/30/2015 | 06/30/2015 | 03/31/2015 | 12/31/2014 | 09/30/2014 | |
|---|---|---|---|---|---|
| Net Income | 51.38% | 53.38% | 36.51% | 16.58% | -- |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -34.37% | -4.11% | 33.07% | 143.39% | -- |
| Total Other Non-Cash Items | -43.84% | -45.27% | -34.57% | -17.74% | -- |
| Change in Net Operating Assets | -110.39% | -135.94% | -135.23% | -105.41% | -- |
| Cash from Operations | 57.96% | 33.43% | 21.87% | -83.95% | -- |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -58.29% | -33.25% | -38.07% | -34.24% | -- |
| Total Debt Repaid | 20.08% | 42.40% | 75.72% | 73.39% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -60.23% | -32.24% | -33.73% | -29.57% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -179.23% | 62.30% | -191.02% | -196.06% | -- |
